Increased co-expression of PSMA2 and GLP-1 receptor in cervical cancer models in type 2 diabetes attenuated by Exendin-4: A translational case-control study
Key Research Features Triple-hormone receptor agonist GIP + GLP-1 + Glucagon (GCGR) Tuned potency hierarchy across all three receptor targets C20 fatty diacid moiety albumin binding, ~6-day half-life in research models Simultaneous energy intake and energy expenditure pathway modeling 99% HPLC-verified purity LC-MS sequence and molecular weight identity confirmed Lyophilized powder format Suitable for in vitro and preclinical research Batch-tested for consistency Research-grade manufacturing standards Professionally labeled and documented Storage Recommendations To maintain product stability and research integrity, Retatrutide should be: Stored at 20C in a tightly sealed container Protected from light and moisture Reconstituted in sterile or bacteriostatic water Kept sealed until use Handled according to standard laboratory procedures Not subjected to repeated freeze-thaw cycles Toxicology and Regulatory Information Currently an Investigational New Drug (IND) under active Phase 3 clinical investigation (TRIUMPH and TRANSCEND trial series) Not FDA-approved for any therapeutic indication as of current date Prohibited by the World Anti-Doping Agency (WADA) under S2 Peptide Hormones, Growth Factors, Related Substances, and Mimetics Supplied strictly as a Research Use Only (RUO) material Why Choose Summit Pep Labs
Pharmacotherapy 42 , 921928 (2022)
A Renewed Sense of Control Ultimately, combining tirzepatide and B12 isnt about a quick fix
VITAMIN C IV THERAPY DRIP All major immune system cell lines function at their peak with ample Vitamin C supplies
For liver: It's believed that glutathione helps the liver rid itself of toxins
